Kalija Permanganats A/S Rīgas Farmaceitiskā Fabrika (Potassium Permanganate)

Potassium permanganate releases free radicals that oxidise essential cellular components of microorganisms. This oxidative damage disrupts proteins, lipids and nucleic acids, leading to rapid microbial death and preventing colonisation of the treated area.

The amount of Kalija Permanganats to apply is determined by the prescribing health professional based on the size and type of the wound or skin area. No fixed dosage is provided; the prescriber sets the appropriate quantity for each case.

Safety data for potassium permanganate in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if clearly needed and after consulting a qualified health‑care provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with common antiseptics such as chlorhexidine or povidone‑iodine, potassium permanganate acts through oxidative mechanisms rather than membrane disruption. It is particularly useful for its broad‑spectrum activity and ability to stain, which can aid visual assessment, but it may cause more skin irritation than milder agents.

Kalija Permanganats should be stored at ambient temperature, in a tightly sealed container, protected from light and moisture. Keep the product out of reach of children and avoid exposure to extreme heat or direct sunlight to maintain its stability.

The product is applied topically to the affected skin area. A thin layer is spread over the wound or cut using a sterile applicator or gauze, allowing the solution to act for a short period before rinsing if required, following the prescriber’s instructions.

Serious risks include chemical burns if applied to large or compromised wounds, severe allergic reactions such as swelling or hives, and systemic toxicity from accidental ingestion. Users should monitor for signs of excessive irritation and seek medical help if severe reactions develop.

Individuals with known hypersensitivity to potassium permanganate or other oxidising agents should avoid its use. It is also contraindicated on extensive open wounds, mucous membranes, eyes, or in patients where systemic absorption could pose a risk, unless directed by a health professional.